Verona Pharma(VRNA) - 2024 Q2 - Quarterly Report

Title of each class Trading Symbol(s) Name of each exchange on which registered Ordinary shares, nominal value £0.05 per share* VRNA The Nasdaq Stock Market LLC (Nasdaq Global Market) Large accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended J ...